Recorded Chinese product: 氟胞嘧啶片氟胞嘧啶片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司
主要成分Active Ingredients
- 氟胞嘧啶Fubao Miding
药物知识说明
氟胞嘧啶是一种在国家药监局注册认定的药品。标注生产企业为中国药科大学制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司、中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司、中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氟胞嘧啶片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 中国药科大学制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司, 中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司, 中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氟胞嘧啶片Recorded Chinese product: 氟胞嘧啶片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.5g*50片0.5 g × 50 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 中国药科大学制药有限公司Chinese legal name: 中国药科大学制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32025798
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32025798
Manufacturer
Chinese legal name: 中国药科大学制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.5 g × 50 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H32025798
生产企业
中国药科大学制药有限公司(国产)
适应症
抗真菌药。用于白色念珠菌及新型隐球菌，肺曲菌病感染
用法用量
口服 一次1.0～1.5g，一日4次，为避免或减少恶心，呕吐，每次服药时间持续15分钟。或遵医嘱。
不良反应
1、本品可致恶心、呕吐、厌食、腹痛、腹泻等胃肠道反应。
2、皮疹、嗜酸性粒细胞增多等变态反应。
3、肝毒性反应可发生，一般表现为血清氨基转移酶一过性升高，偶见血清胆红素升高，肝肿大者甚为少见。
4、可致白细胞或血小板减少，偶可发生全血细胞减少，骨髓抑制和再生障碍性贫血。合用两性霉素B者较单用本品为多见，此不良反应的发生与血药浓度过高有关。
5、偶可发生暂时性神经精神异常，表现为精神错乱、幻觉、定向力障碍和头痛、头晕等。
禁忌
严重肾功能不全及对本品过敏患者禁用。
注意事项
用药期间应定期检查血象。血液病患者，肝功能减退者，孕妇慎用。肾功能严重减退及对本品敏者忌用。
贮藏
遮光，密闭，在阴凉处保存。
规格
0.5g*50片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.